PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
2011

PKCδ Sensitizes Neuroblastoma Cells to Chemotherapy

publication 10 minutes Evidence: moderate

Author Information

Author(s): Marengo Barbara, De Ciucis Chiara, Ricciarelli Roberta, Passalacqua Mario, Nitti Mariapaola, Zingg Jean-Marc, Marinari Umberto M., Pronzato Maria A., Domenicotti Cinzia

Primary Institution: University of Genoa, Genoa, Italy

Hypothesis

Can PKCδ enhance the sensitivity of neuroblastoma cells to oxidative stress and chemotherapy?

Conclusion

PKCδ overexpression increases DNA damage and apoptosis in neuroblastoma cells, making them more sensitive to chemotherapy.

Supporting Evidence

  • PKCδ overexpression leads to increased ROS production in neuroblastoma cells.
  • Cells treated with BSO showed enhanced apoptosis when PKCδ was overexpressed.
  • Blocking ROS production prevented apoptosis in PKCδ-overexpressing cells.
  • DNA damage was significantly higher in PKCδ-overexpressing cells after treatment with BSO.
  • Silencing PKCδ reduced the sensitivity of neuroblastoma cells to chemotherapy.

Takeaway

This study shows that a protein called PKCδ helps cancer cells die when treated with certain drugs, which could help doctors treat cancer better.

Methodology

The study involved transfecting neuroblastoma cell lines with PKCδ and assessing ROS production, apoptosis, and DNA damage after treatment with BSO and etoposide.

Limitations

The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.

Participant Demographics

Human neuroblastoma cell lines were used, including MYCN-amplified and non-amplified types.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0014661

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication